Response criteria for NHL: Importance of ‘normal’ lymph node size and correlations with response rates
Open Access
- 1 April 2000
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 11 (4) , 399-408
- https://doi.org/10.1023/a:1008332713631
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's LymphomasJournal of Clinical Oncology, 1999
- Cladribine and mitoxantrone dose escalation in indolent non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1996
- Fludarabine: A Phase II Trial in Patients with Previously Treated Low-Grade LymphomaAmerican Journal of Clinical Oncology, 1996
- Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1995
- 2'-Chlorodeoxyadenosine: evaluation of a novel predominantly lymphocyte selective agent in lymphoid malignanciesBritish Journal of Cancer, 1993
- Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.Journal of Clinical Oncology, 1992
- Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study.Journal of Clinical Oncology, 1992
- Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.Journal of Clinical Oncology, 1990
- Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.Journal of Clinical Oncology, 1989
- Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)Blood, 1988